476 related articles for article (PubMed ID: 22672477)
81. HLA-DQ Mismatching and Kidney Transplant Outcomes.
Leeaphorn N; Pena JRA; Thamcharoen N; Khankin EV; Pavlakis M; Cardarelli F
Clin J Am Soc Nephrol; 2018 May; 13(5):763-771. PubMed ID: 29685925
[TBL] [Abstract][Full Text] [Related]
82. The influence of histocompatibility on graft rejection and graft survival within a single center population of heart transplant recipients.
Sheldon S; Yonan NA; Aziz TN; Hasleton PS; Rahman AN; Deiraniya AK; Campbell CS; Dyer PA
Transplantation; 1999 Aug; 68(4):515-9. PubMed ID: 10480409
[TBL] [Abstract][Full Text] [Related]
83. Sharing cross-reactive groups of MHC class I improves long-term graft survival.
Sijpkens YW; Doxiadis II; De Fijter JW; Mallat MJ; van Es LA; De Lange P; Zwinderman AH; Westendorp RG; van Kemenade FJ; Bruijn JA; Claas FH; Paul LC
Kidney Int; 1999 Nov; 56(5):1920-7. PubMed ID: 10571803
[TBL] [Abstract][Full Text] [Related]
84. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
[TBL] [Abstract][Full Text] [Related]
85. Re-Examining Risk of Repeated HLA Mismatch in Kidney Transplantation.
Tinckam KJ; Rose C; Hariharan S; Gill J
J Am Soc Nephrol; 2016 Sep; 27(9):2833-41. PubMed ID: 26888475
[TBL] [Abstract][Full Text] [Related]
86. Influence of HLA-DQ Matching on Allograft Outcomes in Deceased Donor Kidney Transplantation.
Khongjaroensakun N; Kitpoka P; Wiwattanathum P; Sakulchairungrueng B; Thammanichanond D
Transplant Proc; 2018 Oct; 50(8):2371-2376. PubMed ID: 30316360
[TBL] [Abstract][Full Text] [Related]
87. Ceppellini Lecture 2012: collateral damage from HLA mismatching in kidney transplantation.
Opelz G; Döhler B
Tissue Antigens; 2013 Oct; 82(4):235-42. PubMed ID: 24461002
[TBL] [Abstract][Full Text] [Related]
88. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
[TBL] [Abstract][Full Text] [Related]
89. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations.
Quantz MA; Bennett LE; Meyer DM; Novick RJ
J Heart Lung Transplant; 2000 May; 19(5):473-9. PubMed ID: 10808155
[TBL] [Abstract][Full Text] [Related]
90. Relevance of HLA compatibility in living donor liver transplantation: the double-edged sword associated with the patient outcome.
Uchiyama H; Kayashima H; Matono R; Shirabe K; Yoshizumi T; Ikegami T; Soejima Y; Matsuura T; Taguchi T; Maehara Y
Clin Transplant; 2012; 26(5):E522-9. PubMed ID: 23061761
[TBL] [Abstract][Full Text] [Related]
91. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.
Schulman LL; Weinberg AD; McGregor C; Galantowicz ME; Suciu-Foca NM; Itescu S
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1833-7. PubMed ID: 9620914
[TBL] [Abstract][Full Text] [Related]
92. Induction Type and Outcomes in HLA-DR Mismatch Kidney Transplantation.
Sureshkumar KK; Chopra B
Transplant Proc; 2019; 51(6):1796-1800. PubMed ID: 31399165
[TBL] [Abstract][Full Text] [Related]
93. Organ allocation in pediatric renal transplants: is there an optimal donor?
Pitt SC; Vachharajani N; Doyle MB; Lowell JA; Chapman WC; Anderson CD; Shenoy S; Wellen JR
Clin Transplant; 2013; 27(6):938-44. PubMed ID: 24224847
[TBL] [Abstract][Full Text] [Related]
94. Impact of HLA mismatch at first kidney transplant on lifetime with graft function in young recipients.
Foster BJ; Dahhou M; Zhang X; Platt RW; Smith JM; Hanley JA
Am J Transplant; 2014 Apr; 14(4):876-85. PubMed ID: 24612783
[TBL] [Abstract][Full Text] [Related]
95. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
[TBL] [Abstract][Full Text] [Related]
96. Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens.
Woodle ES; Susskind B; Alloway RR; Hanaway MJ; Thomas M; Buell J; Alexander JW; Roy-Chaudhury P; Succop P; Cardi M; Boardman R; Rogers C
Transplant Proc; 2005 Mar; 37(2):809-11. PubMed ID: 15848539
[TBL] [Abstract][Full Text] [Related]
97. Human leukocyte antigen compatibility and lymphocyte cross-matching play no significant role in the current adult-to-adult living donor liver transplantation.
Badawy A; Kaido T; Yoshizawa A; Yagi S; Fukumitsu K; Okajima H; Uemoto S
Clin Transplant; 2018 Apr; 32(4):e13234. PubMed ID: 29499077
[TBL] [Abstract][Full Text] [Related]
98. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival.
Smedbråten YV; Sagedal S; Leivestad T; Mjøen G; Osnes K; Rollag H; Reisaeter AV; Foss A; Os I; Hartmann A
Clin Transplant; 2014 Jan; 28(1):120-6. PubMed ID: 24351078
[TBL] [Abstract][Full Text] [Related]
99. Recipient-related risk factors for graft failure and death in elderly kidney transplant recipients.
Lai X; Chen G; Qiu J; Wang C; Chen L
PLoS One; 2014; 9(11):e112938. PubMed ID: 25389964
[TBL] [Abstract][Full Text] [Related]
100. The impact of late acute rejection after cadaveric kidney transplantation.
Joseph JT; Kingsmore DB; Junor BJ; Briggs JD; Mun Woo Y; Jaques BC; Hamilton DN; Jardine AG; Jindal RM
Clin Transplant; 2001 Aug; 15(4):221-7. PubMed ID: 11683814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
